Godfrey Harding
Impact in
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research
- Viral gastroenteritis research and epidemiology
- Antimicrobial Resistance in Staphylococcus
- Infection Control in Healthcare
-
- Nosocomial Infections in ICU
Papers in
-
- Clostridium difficile and Clostridium perfringens research 3
- Viral gastroenteritis research and epidemiology 2
-
- Microscopic Colitis 1
- Sepsis Diagnosis and Treatment 1
- Co-authors
- Michelle J. Alfa (6 shared papers)Amin Kabani (2 shared papers)David M. Lyerly (1 shared paper)Karen Olekson (1 shared paper)John M. Embil (2 shared papers)Ali Albarrak (1 shared paper)Sat Sharma (1 shared paper)Michael Helewa (2 shared papers)
- Journals
- Journal of Clinical Microbiology (2 papers)Drugs (1 paper)Infection (1 paper)American Journal of Kidney Diseases (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- CanadaSaudi ArabiaUnited States
In The Last Decade
Godfrey Harding
11 papers receiving 313 citations
Peers
Comparison fields: 5 of 48
- Infectious Diseases 248
- Critical Care and Intensive Care Medicine 33
- Applied Microbiology and Biotechnology 10
- Epidemiology 157
- Parasitology 27
Countries citing papers authored by Godfrey Harding
This map shows the geographic impact of Godfrey Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Godfrey Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Godfrey Harding more than expected).
Fields of papers citing papers by Godfrey Harding
This network shows the impact of papers produced by Godfrey Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Godfrey Harding. The network helps show where Godfrey Harding may publish in the future.
Co-authors
The 25 scholars most cited alongside Godfrey Harding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 193 | |
| 2 | 2010 | 36 | |
| 3 | 2008 | 29 | |
| 4 | 2003 | 29 | |
| 5 | 1998 | 16 | |
| 6 | 2000 | 13 | |
| 7 | 1993 | 7 | |
| 8 | 1996 | 6 | |
| 9 | 1999 | 5 | |
| 10 | 2000 | 1 | |
| 11 | 2004 | 1 |
About Godfrey Harding
Godfrey Harding is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Surgery, having authored 11 papers that have together received 336 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (3 papers), Streptococcal Infections and Treatments (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Neonatal and Maternal Infections (2 papers), Microscopic Colitis (1 paper), Pediatric Urology and Nephrology Studies (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (248 citations), Critical Care and Intensive Care Medicine (33 citations), Applied Microbiology and Biotechnology (10 citations), Epidemiology (157 citations) and Parasitology (27 citations). Godfrey Harding has collaborated with scholars based in Canada, Saudi Arabia and United States. Frequent co-authors include Michelle J. Alfa, Amin Kabani, David M. Lyerly, Karen Olekson, John M. Embil, Ali Albarrak, Sat Sharma, Michael Helewa, Tariq A. Madani and George G. Zhanel. Their work appears in journals such as Journal of Clinical Microbiology, Drugs, Infection, American Journal of Kidney Diseases and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.